Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 711 (ZNF711) is a nuclear transcription factor that contains classical C2H2-type zinc finger domains, binds DNA in a sequence-specific manner, and is crucial for brain and neuron development. It is located on the X chromosome, and disruptions or mutations in ZNF711 are associated with intellectual developmental disorders, specifically forms of X-linked intellectual disability. ZNF711 regulates gene expression by acting at gene promoters and interacting with the histone demethylase PHF8, thus modulating neuronal gene transcription, such as activation of KDM5C. Recent structural studies confirm that even its “degenerate” seventh zinc finger domain forms a stable fold and may play a role in catalysis and DNA recognition. ZNF711 is not currently considered a direct therapeutic drug target, and there are no known small-molecule drugs that modulate this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 711 (ZNF711).